Literature DB >> 320878

Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide.

M Schebalin, S I Said, G M Makhlouf.   

Abstract

In vivo, vasoactive intestinal peptide (VIP) produces simultaneous increases in blood glucose and insulin levels. In order to determine whether VIP, like its homologues, also stimulates insulin secretion directly, studies were made in controlled glucose media employing the vascularly perfused cat pancreas. VIP stimulated insulin secretion significantly in the presence of constant physiological concentrations of glucose. The highest insulin response to VIP (100.3+/-8.1 muU/min) approached the highest insulin response to glucose (119.9 +/- 12.0 muU/min). In the absence of glucose, the insulin response to VIP was insignificant. Unexpectedly, VIP was found to be a more effective stimulant of glucagon than of insulin secretion. The highest glucagon response to VIP (327+/-51% of control levels) was attained in the presence of physiological concentrations of glucose and equalled the glucagon response obtained upon withdrawal of glucose from the perfusate. The glucagon response to VIP was blocked by increasing the glucose in the perfusate. These studies indicate the VIP present in pancreatic islets might play a role in the local control of pancreatic endocrine function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320878     DOI: 10.1152/ajpendo.1977.232.2.E197

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity.

Authors:  Yong-Jun Liu; Yan-Fang Guo; Li-Shu Zhang; Yu-Fang Pei; Na Yu; Ping Yu; Christopher J Papasian; Hong-Wen Deng
Journal:  Obesity (Silver Spring)       Date:  2010-04-08       Impact factor: 5.002

2.  Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo.

Authors:  V Sánchez; R Goberna; J R Calvo
Journal:  Experientia       Date:  1991-06-15

3.  Helodermin and islet hormone release in isolated rat pancreas.

Authors:  H C Fehmann; R Göke; B Göke; R Eissele; R Arnold
Journal:  Int J Pancreatol       Date:  1991-05

4.  Quadruple colocalization of calretinin, calcitonin gene-related peptide, vasoactive intestinal peptide, and substance P in fibers within the villi of the rat intestine.

Authors:  K R Isaacs; L Winsky; K I Strauss; D M Jacobowitz
Journal:  Cell Tissue Res       Date:  1995-06       Impact factor: 5.249

Review 5.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

6.  Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

Authors:  D P Taylor; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  The endocrine pancreas of Alligator mississippiensis. An immunocytochemical investigation.

Authors:  A M Buchan; V Lance; J M Polak
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

8.  Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.

Authors:  P J Magistretti; J H Morrison; W J Shoemaker; V Sapin; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Interactions between autonomic nerves and endocrine cells of the gastroenteropancreatic system.

Authors:  P H Smith; Katherine L Madson
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

10.  Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.

Authors:  G Bertrand; R Puech; Y Maisonnasse; J Bockaert; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.